These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34176088)

  • 1. Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit.
    Russo A; Gavaruzzi F; Ceccarelli G; Borrazzo C; Oliva A; Alessandri F; Magnanimi E; Pugliese F; Venditti M
    Infection; 2022 Feb; 50(1):83-92. PubMed ID: 34176088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission.
    Blanco N; Harris AD; Rock C; Johnson JK; Pineles L; Bonomo RA; Srinivasan A; Pettigrew MM; Thom KA;
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China.
    Yu K; Zeng W; Xu Y; Liao W; Xu W; Zhou T; Cao J; Chen L
    Antimicrob Resist Infect Control; 2021 Jan; 10(1):16. PubMed ID: 33461617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.
    Huang H; Chen B; Liu G; Ran J; Lian X; Huang X; Wang N; Huang Z
    BMC Infect Dis; 2018 Jan; 18(1):11. PubMed ID: 29304746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit.
    Jung JY; Park MS; Kim SE; Park BH; Son JY; Kim EY; Lim JE; Lee SK; Lee SH; Lee KJ; Kang YA; Kim SK; Chang J; Kim YS
    BMC Infect Dis; 2010 Jul; 10():228. PubMed ID: 20670453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
    Karruli A; Boccia F; Gagliardi M; Patauner F; Ursi MP; Sommese P; De Rosa R; Murino P; Ruocco G; Corcione A; Andini R; Zampino R; Durante-Mangoni E
    Microb Drug Resist; 2021 Sep; 27(9):1167-1175. PubMed ID: 33600262
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular epidemiology of multidrug-resistant clinical isolates of Acinetobacter baumannii : A 10-year analysis in a large tertiary care university hospital in central Europe with international admissions.
    Segagni Lusignani L; Starzengruber P; Dosch V; Assadian O; Presterl E; Diab-Elschahawi M
    Wien Klin Wochenschr; 2017 Nov; 129(21-22):816-822. PubMed ID: 28776101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-drug resistant Acinetobacter species: a seven-year experience from a tertiary care center in Lebanon.
    Kanafani ZA; Zahreddine N; Tayyar R; Sfeir J; Araj GF; Matar GM; Kanj SS
    Antimicrob Resist Infect Control; 2018; 7():9. PubMed ID: 29387343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for acquired multidrug-resistant Acinetobacter baumannii colonization in respiratory intensive care unit].
    Wang HL; Sui WJ; Wang JR; Wang M; Huang YF; Gu HT; Pang J; Lu XX
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(14):960-3. PubMed ID: 22781568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.
    Holloway KP; Rouphael NG; Wells JB; King MD; Blumberg HM
    Ann Pharmacother; 2006 Nov; 40(11):1939-45. PubMed ID: 17018688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.
    Smolyakov R; Borer A; Riesenberg K; Schlaeffer F; Alkan M; Porath A; Rimar D; Almog Y; Gilad J
    J Hosp Infect; 2003 May; 54(1):32-8. PubMed ID: 12767844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.
    Tacconelli E; Cataldo MA; De Pascale G; Manno D; Spanu T; Cambieri A; Antonelli M; Sanguinetti M; Fadda G; Cauda R
    J Antimicrob Chemother; 2008 Nov; 62(5):1130-7. PubMed ID: 18635519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infection of patients admitted in intensive care unit: a systematic review and meta-analysis.
    Diao H; Lu G; Zhang Y; Wang Z; Liu X; Ma Q; Yu H; Li Y
    J Hosp Infect; 2024 Jul; 149():77-87. PubMed ID: 38710306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
    Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
    J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency And Clinical Spectrum Of Multidrug Resistant Acinetobacter Baumannii As A Significant Nosocomial Pathogen In Intensive Care Unit Patients.
    Sana F; Hussain A; Hussain W; Zaman G; Abbas MW; Imtiaz A; Satti L
    J Ayub Med Coll Abbottabad; 2021; 33(Suppl 1)(4):S752-S756. PubMed ID: 35077621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between antibiotic pressure and the risk of colonization/infection by multidrug-resistant Acinetobacter baumannii complex: a time series analysis.
    Huertas Vaquero M; Asencio Egea MA; Carranza González R; Padilla Serrano A; Conde García MC; Tenias Burillo JM; Redondo González O
    Rev Esp Quimioter; 2021 Dec; 34(6):623-630. PubMed ID: 34610732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients.
    Lin CY; Chen YM; Lin MC; Chang YP; Chao TY; Wang CC; Tsai YC; Shen LS; Li CL; Lin AS
    Biomed J; 2016 Apr; 39(2):130-8. PubMed ID: 27372168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
    Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
    Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial Acinetobacter baumannii infection in children in adult versus pediatric intensive care units.
    Kim B; Kim K; Yoon JS
    Pediatr Int; 2020 Apr; 62(4):451-458. PubMed ID: 31887243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.